MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
MetLife, Inc.NYSE: MET
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses dips below year-ago levels
Q2 FY2026 operating expenses of $1.75B fell 50.8% year over year, behind the +9.8% change in trailing-twelve-month operating expenses. Sequentially, it fell 68.7% from the prior quarter. Over 3 fiscal years it compounded at +22.9% a year.
Context
- Operating expenses amounted to 30.3% of revenue in FY2025, up 11.2 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -50.8% toward the trailing-twelve-month pace of +9.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 23.36B USD
- Year-over-year change
- +74.7%
- 4-year CAGR
- +29.5%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.36B | +74.7% |
| FY2024 | 2024-12-31 | 13.38B | -11.6% |
| FY2023 | 2023-12-31 | 15.13B | +20.3% |
| FY2022 | 2022-12-31 | 12.57B | +51.2% |
| FY2021 | 2021-12-31 | 8.32B | — |
Operating Expenses vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +9.8% is the 8th highest of 11, against a peer median of +57.0%.
- Operating expenses amounts to 19.4% of revenue for MET, versus a peer median of 34.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CA$18.73B CAD | -36.2% | +10.4% | 32.3% | |
| LTM Jun 2026 | $15.23B USD | +9.8% | +22.9% | 19.4% | |
| LTM Jun 2026 | $14.96B USD | +8.2% | +1.2% | 23.1% | |
| LTM Jun 2026 | $8.29B USD | +148.3% | +134.2% | 42.8% | |
| LTM Jun 2026 | $3.94B USD | +165.0% | -46.8% | 21.8% | |
| LTM Jun 2026 | $3.82B USD | -7.8% | +23.0% | 28.9% | |
| LTM Jun 2026 | $2.91B USD | +180.7% | +12.6% | 77.3% | |
| LTM Sep 2026 | $2.41B USD | +85.8% | +28.8% | 44.4% | |
| LTM Jun 2026 | $1.66B USD | +25.8% | +20.8% | 35.8% | |
| LTM Sep 2026 | $1.33B USD | +245.8% | +72.8% | 38.5% | |
| LTM Sep 2026 | $756.62M USD | +28.3% | +7.2% | 12.0% | |
| Peer median (excluding MET) | — | +57.0% | +16.7% | 34.1% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.